Maxim Le Compte

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen et al. · Journal of Hematology & Oncology · 2024 · 95 citations · Full text

Medicine, Immunology, Oncology +17

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening

Christophe Deben, Edgar Cardenas De La Hoz, Maxim Le Compte et al. · Cellular Oncology · 2022 · 80 citations · Full text

Medicine, Bioengineering, Oncology +17

Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer

Maxim Le Compte, Edgar Cardenas De La Hoz, Sofía Peeters et al. · npj Precision Oncology · 2023 · 37 citations · Full text

Medicine, Cell Biology, Oncology +17

Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays

Christophe Deben, Edgar Cardenas De La Hoz, Felicia Rodrigues Fortes et al. · Communications Biology · 2024 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +16

Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

Christophe Deben, Laurie Freire Boullosa, Felicia Rodrigues Fortes et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17